Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.5B | 6.1B | 5.2B | 3.3B |
Cost of revenue | 3.1B | 5.0B | 4.6B | 3.1B |
Gross profit | 359M | 1.1B | 544M | 156M |
Operating expense | ||||
Research & development | 110M | 107M | 99M | 89M |
Selling general and admin | 235M | 248M | 211M | 252M |
Other operating expenses | — | — | — | — |
Operating income | 14M | 758M | 234M | -185M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 7M | 856M | 184M | -230M |
Tax provision | 2M | 258M | 57M | -74M |
Net income | 5M | 598M | 127M | -156M |
Basic EPS | 0 | — | 0.1 | -0.2 |
Diluted EPS | 0 | — | 0.1 | -0.2 |
Basic average shares | 134.9M | — | 130.8M | 132.2M |
Diluted average shares | 134.9M | — | 130.8M | 132.2M |
EBITDA | 8M | 858M | 238M | -185M |
Net income from continuing op. | 5M | 598M | 127M | -156M |
Minority interests | 0 | 0 | 0 | -2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |